RahulLakhotiaMD

Physician

Dr. Lakhotia is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
110 Irving St Nw
Dept Of Medicine
Washington, DC 20010
Phone+1 202-877-8278

Fax+1 202-877-6292

MedStar Health/Georgetown University HospitalResidency, Internal Medicine, 2013 - 2016
Seth G.S. Medical CollegeClass of 2012
National Institutes of Health Clinical CenterFellowship, Medical Oncology

PubMed

1 citations
Combination Targeted Therapy in Relapsed Diffuse Large B-Cell Lymphoma.
Christopher Melani, Rahul Lakhotia, Stefania Pittaluga, James D Phelan, Da Wei Huang
The New England Journal of Medicine. 2024-06-20
Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R.
Rahul Lakhotia, Kieron Dunleavy, Jeremy S Abramson, Brian K Link, Bayard L Powell
Blood Advances. 2023-09-26
2 citations
Clinical applications of circulating tumor DNA in indolent B-cell lymphomas.
Rahul Lakhotia, Mark Roschewski
Seminars in Hematology. 2023-07-01

Abstracts/Posters

Phase 1b Study of Vipor (Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Lenalidomide) in Relapsed/Refractory B-Cell Lymphoma: Safety, Efficacy and Molecular Anal...
Rahul Lakhotia, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019